Main Menu

Amylin Pharmaceuticals files against Eli Lilly


By Sasha B. Coffiner

Excerpt "Based on his experience, Phil Fowler, a corporate partner at Bingham McHale, said Lilly is 'very astute' in entering into these types of agreements and it is unlikely that the agreement contains language that would not have allowed Lilly to pursue any other options in diabetes." Read the full article here.

Back to Page